{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:07:36Z","timestamp":1760731656478,"version":"3.41.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Microvascular thrombosis is key to the pathogenesis of calciphylaxis. C5b-9\u2013mediated microvascular injury reflective of complement pathway activation could be a key pathophysiologic event.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective multicenter study of 24 patients who have had biopsy-supported calciphylaxis from the 2010\u20132022 data base from Emory where C5b-9 immunohistochemistry (IHC) had not been conducted and the 2019\u20132023 data base from Cornell where C5b-9 IHC was done as part of the routine calciphylaxis work up. IHC for C5b-9 on lesional biopsy specimens was assessed and correlated with routine light microscopic findings and clinical features.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Most of the patients in our study had uremic calciphylaxis associated with obesity, diabetes, dialysis, hypertension, hyperparathyroidism and elevated serum phosphorus. Most patients did not have defined procoagulant and\/or hyperviscosity states. The vascular pathology was predominantly limited to the subcutaneous fat and ranged from a calcific intimal arteriopathy to microvascular thrombosis with endothelial injury with or without endothelial calcification. In most cases (ie, in excess of 80%), there was prominent deposition of C5b-9 within the vasculature including the microvasculature and arteries of the fat at least localized to injured vessels suggesting a causal association. In about 40% of cases, there was evidence of systemic complement pathway activation revealed by concurrent dermal microvascular C5b-9 deposition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Calciphylaxis is characterized by subcuticular vascular changes that reflect an interplay between complement triggered endothelial cell injury, resultant vascular thrombosis, and subsequent abluminal calcification. Complement inhibition therapy defines a potential intervention that should be explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dad.0000000000002783","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T17:00:37Z","timestamp":1732122037000},"page":"807-818","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Redefining Calciphylaxis as a Uniquely Bone Forming Subcutaneous C5b-9\u2013Mediated Microvascular Injury Syndrome Associated With Localized Subcutaneous and Systemic Complement Pathway Activation"],"prefix":"10.1097","volume":"46","author":[{"given":"Zachary","family":"Wolner","sequence":"first","affiliation":[{"name":"Dermatologist, Department of Dermatology, Emory School of Medicine, Atlanta, GA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Tello","sequence":"additional","affiliation":[{"name":"Pathologist, Department of Pathology, Emory School of Medicine, Atlanta, GA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Kalomeris","sequence":"additional","affiliation":[{"name":"Pathologist, Department of Pathology and Laboratory Medicine, New York Presbyterian\/Weill Cornell Medicine, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Swerlick","sequence":"additional","affiliation":[{"name":"Dermatologist, Department of Dermatology, Emory School of Medicine, Atlanta, GA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Magro","sequence":"additional","affiliation":[{"name":"Pathologist, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2021.10.064","article-title":"Calciphylaxis: Part I. Diagnosis and pathology","volume":"86","author":"Rick","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250616","first-page":"461","article-title":"On the role of adjuvants in calciphylaxis","volume":"15","author":"Selye","year":"1961","journal-title":"Q Rev Allergy Appl Immunol"},{"key":"R3-20250616","first-page":"241","article-title":"Calciphylaxis","volume":"7","author":"Selye","year":"1961","journal-title":"Allerg Asthma (Leipz)"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(68)90531-X","article-title":"Calcifying panniculitis with fat and skin necrosis in a case of uraemia with autonomous hyperparathyroidism","volume":"2","author":"Anderson","year":"1968","journal-title":"Lancet"},{"key":"R5-20250616","first-page":"66","article-title":"Calciphylaxis: a review","volume":"2","author":"Magro","year":"2010","journal-title":"J Am Col Certif Wound Spec"},{"key":"R6-20250616","first-page":"35","article-title":"Fliuorestsentnaia angiografiia pri zasto\u012dnykh i psevdozasto\u012dnykh diskakh zritel'nykh nervov [Fluorescence angiography in congestion and pseudocongestion of the optic disks]","volume":"10","author":"Pureskin","year":"1975","journal-title":"Voen Med Zh"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaad.2021.10.063","article-title":"Calciphylaxis: treatment and outlook-CME part II","volume":"86","author":"Rick","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2023.07.1031","article-title":"A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis","volume":"90","author":"Biglione","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00256-020-03579-6","article-title":"Concomitant calciphylaxis and COVID-19 associated thrombotic retiform purpura","volume":"49","author":"Rotman","year":"2020","journal-title":"Skeletal Radiol"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.clindermatol.2021.07.001","article-title":"The skin as a critical window in unveiling the pathophysiologic principles of COVID-19","volume":"39","author":"Magro","year":"2021","journal-title":"Clin Dermatol"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2017.4920","article-title":"Association between hypercoagulable conditions and calciphylaxis in patients with renal disease: a case-control study","volume":"154","author":"Dobry","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"10760296231195089","DOI":"10.1177\/10760296231195089","article-title":"Potential biomarkers for early diagnosis, evaluation, and prognosis of sepsis-induced coagulopathy","volume":"29","author":"Li","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41409-022-01723-5","article-title":"C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"57","author":"Elhadad","year":"2022","journal-title":"Bone Marrow Transpl"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2020.10.002","article-title":"Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019","volume":"106","author":"Magro","year":"2020","journal-title":"Hum Pathol"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archinte.1974.00320140122013","article-title":"Pulmonary alveolar proteinosis","volume":"133","author":"McClenahan","year":"1974","journal-title":"Arch Intern Med"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","article-title":"Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment","volume":"15","author":"Wilmer","year":"2002","journal-title":"Semin Dial"},{"key":"R19-20250616","first-page":"265","article-title":"Non-uremic calciphylaxis","volume":"115","author":"Holtsche","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1684\/ejd.2014.2448","article-title":"Osteopontin expression in biopsies of calciphylaxis","volume":"25","author":"Magro","year":"2015","journal-title":"Eur J Dermatol"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"138797","DOI":"10.1155\/2012\/138797","article-title":"Human L-ficolin (ficolin-2) and its clinical significance","volume":"2012","author":"Kilpatrick","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.imbio.2006.12.004","article-title":"New perspectives on mannan-binding lectin-mediated complement activation","volume":"212","author":"Degn","year":"2007","journal-title":"Immunobiology"},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41581-018-0002-x","article-title":"Haemodialysis membranes","volume":"14","author":"Ronco","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaad.2006.05.013","article-title":"Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda","volume":"56","author":"Vasil","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"bcr2015214142","DOI":"10.1136\/bcr-2015-214142","article-title":"Warfarin-induced calciphylaxis","volume":"2016","author":"Al-ani","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jcpt.12411","article-title":"Warfarin-induced calciphylaxis in patients with normal renal function","volume":"41","author":"Huilaja","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"R27-20250616","first-page":"12","article-title":"The relationship between obesity and calciphylaxis: a review of the literature","volume":"62","author":"Davis","year":"2016","journal-title":"Ostomy Wound Manage"},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/ijd.13685","article-title":"Direct oral anticoagulant medications in calciphylaxis","volume":"56","author":"King","year":"2017","journal-title":"Int J Dermatol"},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"e000996","DOI":"10.1136\/lupus-2023-000996","article-title":"Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational study","volume":"10","author":"Anderson","year":"2023","journal-title":"Lupus Sci Med"},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/bjh.17783","article-title":"Early use of eculizumab for catastrophic antiphospholipid syndrome","volume":"196","author":"Faguer","year":"2022","journal-title":"Br J Haematol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:03:27Z","timestamp":1750097007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002783","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}